PATENT CLAIM ANALYSIS

Application Number: 16179050
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["540", "555000"]

Abstract:
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C  receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C  receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C  receptor.

Claim (Index 56):
The compound as claimed in  claim 53  or the use as claimed in  claim 54  or the method as claimed in  claim 55 , where the disorders are selected from the group consisting of damage of the central nervous system, disorders of the central nervous system, eating disorders, ocular hypertension, cardiovascular disorders, gastrointestinal disorders and diabetes.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.88636
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13838788', '14657840', '14657916', '14026354', '14868835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7679839545906534
- 35 USC 102 Novelty (BERT): 0.5795861803498062
- Combined Prediction Score: 0.7491441771665687
- Mean Citation Score: 483.115398
- Max Citation Score: 558.0024
- Similarity Product: 345.1560777651787

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test